SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,933.59 -539.35
( -0.70%)

Global Indices

Nasdaq

53,487.87 -110.53
(-0.21%)

Dow Jones

7,697.38 -0.90
(-0.01%)

Hang Seng

66,058.92 -203.24
(-0.31%)

Nikkei 225

10,795.58 -82.54
(-0.76%)

Forex

USD-INR

95.31 -0.39
(-0.41%)

EUR-INR

111.19 -0.48
(-0.43%)

GBP-INR

129.97 -0.53
(-0.40%)

JPY-INR

0.60 0.00
(-0.54%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Wanbury Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524212

INE107F01022

41.3181644

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

WANBURY

15.02

891.31

EPS(TTM)

Face Value()

Div & Yield %

16.97

Back

Gammon India reports consolidated net loss of Rs 370.15 crore in the June 2026 quarter

Aug 10,2026

Net Loss of Gammon India reported to Rs 370.15 crore in the quarter ended June 2026 as against net loss of Rs 193.43 crore during the previous quarter ended June 2025. Sales rose 50.00% to Rs 2.19 crore in the quarter ended June 2026 as against Rs 1.46 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2.19	1.46	50
OPM %	-1053.42	-156.85	-
PBDT	-371.64	-193.10	-92
PBT	-372.04	-193.54	-92
NP	-370.15	-193.43	-91

76,933.59 -539.35 ( -0.70%)

53,487.87 -110.53 (-0.21%)

7,697.38 -0.90 (-0.01%)

66,058.92 -203.24 (-0.31%)

10,795.58 -82.54 (-0.76%)

95.31 -0.39 (-0.41%)

111.19 -0.48 (-0.43%)

129.97 -0.53 (-0.40%)

0.60 0.00 (-0.54%)